| |
|
|
|
SC Pharmaceuticals Inc  
|
|
7.12 -0.05 (-0.01%) |
09-25 16:00 |
|
Open: |
7.17 |
Pre close: |
7.17 |
Target:
|
9.73
|
|
High: |
7.2921 |
Low: |
7.02 |
Resistance:
|
8.33
9.19
|
|
Volume: |
60,668 |
Market Cap: |
195M |
Support:
|
6.95
5.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.26
 |
MACD |
MACD(12,26):
|
-0.25 |
|
MA(20): |
7.80 |
Signal(12,26,9): |
-0.16 |
|
MA(100): |
8.16 |
Stochastic Oscillator |
%K(14,3):
|
7.83 |
|
MA(250): |
7.23  |
%D(3): |
8.76 |
|
Average Volume(K) |
3-Month: |
6807
|
52-Week |
High:
|
11.99 |
|
10-Days: |
7450 |
Low: |
4.01 |
|
RSI |
RSI(14):
|
36.87 |
Change(%): |
21.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.600 |
Return on Equity (ttm) |
-40.1 |
Shares Out. (M) |
27.32 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-20.6 |
Shares Float (M) |
8.20 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.97 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
60.12 |
|
Forward EPS |
-1.770 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
233 |
|
Book Value (p.s.) |
3.590 |
EBITDA (p.s.) |
-1.249 |
P/E |
-4.45 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.98 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-34.12 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-24.45 |
P/CF |
-5.70 |
|
|
|
|
|
|
